With the shutdown ongoing, Evommune plans to close its IPO on Nov. 5 via a Securities Act clause that allows registrations to ...

Australian learning platform expands to U.S. classrooms with debut at NABT 2025 in St. Louis. ST. LOUIS, MO / ACCESS Newswire / October 28, 2025 / BioBrain, the innovative digital learning platform ...

Nanobiotix is continuing to find fresh ways to eke money out of its Johnson & Johnson-partnered, phase 3-stage cancer drug. | ...

The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being ...

The Russell 2500 Index was up 9.00%. The Wasatch Long/Short Alpha Fund—Investor Class did not keep pace and finished the ...

Calluna Pharma AS, a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced that it has received Orphan Drug Designation ...

Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.

Professor Tom Alter is appealing to Texas’s Board of Regents after being temporarily reinstated and then fired again.

Nanobiotix cash visibility into early 2028Transaction enables Nanobiotix development beyond key milestones in head and neck cancer and lung cancerFinancing establishes financial foundation toward self ...

Germany: Boehringer Ingelheim and Kyowa Kirin Co., Ltd. have announced that Boehringer Ingelheim has licensed a pre-clinical ...

Within a wide range of interdisciplinary studies at UC Irvine, every major has different expectations, demands, workloads and ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...